Skip to content

Vascular interventional surgical Robot-assisted transcatheter mitral valve Edge-to-edge repair

Vascular interventional surgical Robot-assisted transcatheter mitral valve Edge-to-edge repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098450
Enrollment
Unknown
Registered
2025-03-07
Start date
2024-03-05
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitral regurgitation

Interventions

Sponsors

Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 62 Years

Inclusion criteria

Inclusion criteria: 1)Age>=18 years old 2)Patients with mitral regurgitation disease with clinical indications of TEER 3)Deemed suitable for TEER surgical assistance system 4)Have been informed of the nature of the study and have signed informed consen

Exclusion criteria

Exclusion criteria: 1) Allergy or resistance to Nitinol, sensitive contrast agents and related 2) Patients who cannot receive anticoagulation or antiplatelet therapy 3) Infected with endocarditis or other active infections 4) Rheumatic mitral valve disease 5) Signs of intracardiac, inferior vena cava or femoral vein thrombosis 6) Breastfeeding, pregnant women 7) Failure/inability/unwillingness to sign informed consent 8) The investigators determined that the patient or mitral valve anatomy was not suitable for robot-assisted TEER therapy

Design outcomes

Primary

MeasureTime frame
Technical Success Rate;

Secondary

MeasureTime frame
Instrumental Success;Surgical Success;Clinical Success;

Countries

China

Contacts

Public ContactPan Xiangbin

Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences

panxiangbin@fuwaihospital.org+86 138 1176 3898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026